Table Of Content

AUTHOR INDEX VOLUME 10 Alvar, Jorge, 298 Dominguez, Geraldina, 521 LaRocco, Mark T., 277 Reimer, Larry G., 444 Anderson, Burt E., 203 Dubey, J. P., 19 Lindsay, David S., 19 Romani, Luigina, 611 Dunn, Bruce E., 720 Lopez-Vélez, Rogelio, 298 Roux, Véronique, 694 Bernard, Kathryn A., 125 Dupont, Bertrand, 477 Lortholary, Olivier, 477 Rutala, William A., 597 Bertolotti, Daniela, 369 Bistoni, Francesco, 611 Fauci, Anthony S., 358 Magliani, Walter, 369 Sanders, Christine C., 220 Black, Carolyn M., 160 Fetherston, Jacqueline D., 35 Marshall, Marilyn M., 67 Sanders, W. Eugene, Jr., 220 Blagburn, Byron L., 19 Funke, Guido, 125 Meis, J. F. G. M., 742 Schmidt, B. L., 185 Blair, Donald C., 650 Miller, Rachel A., | Stanley, Samuel L., Jr., 637 Blaser, Martin J., 720 Gerloni, Mara, 369 Molina, Ricardo, 298 Sterling, Charles R., 67 Bloom, David C., 419 Goossens, Herman, 242 Moreno, Javier, 298 Bottone, Edward J., 257 Gutiérrez-Solar, Beatriz, 298 Braun, Daniel K., 521 Naumovitz, Donna, 67 van Belkum, Alex, 505 Britigan, Bradley E., | Hadley, W. Keith, 401 Neuman, Mark A., 203 Verbrugh, Henri, 505 Burgert, Susan J., 277 Hof, H., 345 Ng, Valerie L., 401 von Graevenitz, Alexander, 125 Hoogkamp-Korstanje, J. A. A., Nichterlein, T., 345 74) Canavate, Carmen, 298 Ortega, Ynes, 67 Wagner, Edward K., 419 Chambers, Henry F., 781 Wassenaar, Trudy M.. 466 Clarridge, Jill E., HI, 125 leven, Margareta, 242 Patel, Robin, 86 Weber, David J., 597 Cohen, Hartley, 720 Paya, Carlos V., 86 Weinstein, Melvin P., 444 Conti, Stefania, 369 Jiménez, Maribel, 298 Pellett, Philip E., 521 Weissman, Drew, 358 Curfs, J. H. A. J., 742 Perry, Robert D., 35 Wilson, Michael L., 444 Kluytmans, Jan, 505 Polonelli, Luciano, 369 Wolf, Marcia K., 569 De Clercq, Erik, 674 Kretschmar, M., 345 Puccetti, Paolo, 611 Woody, Hannah B., 320 Deepe, George S., Jr., 585 Domingue, Gerald J., Sr., 32( Laguna, Fernando, 298 Raoult, Didier, 694 Yajko, David M., 401 SUBJECT INDEX VOLUME 10 Amebiasis Interleukin-12 selective, search for, 674 vaccines infectious diseases, 61 | progress towards development, 637 Isospora Yeasts biology killer systems, 369 Bacteremia domestic animals, 19 Yersinia enterocolitica detection, 444 humans, 19 Bacterial persistence nonhuman primates, 19 continuing charisma, 257 disease expression, 320 Yersinia pestis Bartonella spp Leishmania plague, 35 emerging human pathogens, 2 human immunodeficiency virus Bone marrow transplantation coinfection, 298 infection, 277 Letters to the editor role of microbiology laboratory, 277 nystatin Borrelia burgdorferi prophylaxis, 368 PCR Listeriosis human infections, 185 management, 345 Campylobacter Nucleic acid amplification toxin production, 466 respiratory tract infections Chlamydia trachomatis relevance of techniques for diagnosis, laboratory diagnosis 25 425 current methods, 160 Nystatin Coryneform bacteria prophylaxis clinical microbiology, 125 letter to the editor, 368 Cytokines primer, 742 Organ transplantation solid Enterobacter spp proliferation at turn of the century, 220 infections, S86 Oxidants Enterotoxigenic Escherichia coli role in microbial pathophysiology, colonization factor antigens occurrence, distribution, and associa- tions, 569 Pneumocystosis extrapulmonary, 401 H serogroups Protozoan pathogens occurrence, distribution, and associa- waterborne, 67 tions, 569 O serogroups Rickettsia occurrence, distribution, associa- tions, 569 rickettsioses paradigms of emerging infectious dis- toxins occurrence, distribution, associa- eases, 694 tions, 569 Staphy lococci Fungal infections methicillin resistance prophylaxis clinical implications, 781 during immunodeficiency, 477 molecular and biochemical basis, 781 during neutropenia, 477 Staphylococcus aureus Fungemia nasal carriage detection, 444 associated risks, 505 epidemiology, 505 Helicobacter pylori underlying mechanisms, 505 chemotherapy, 720 detection, 720 Travel medicine Herpes simplex virus travel clinics latency, 419 week in the life of, 650 Human herpesvirus 6 variants A and B, 521 Vaccines Human immunodeficiency virus infection amebiasis immunopathogenesis progress towards development, 637 role of dendritic cells, 358 fungal Hypochlorite prospects for development, 585 inorganic Virus infections uses in health-care facilities, chemotherapy